The Traderszone Network

Published in TZ Latest News 4 August, 2017 by The TZ Newswire Staff

Here’s Why Agenus Inc. Stock Slipped 13.6% in July

Shares of Agenus Inc. (NASDAQ: AGEN), a clinical-stage immuno-oncology company, fell 13.6% in July according to data from S&P Global Market Intelligence. Investors viewed a clinical-trial failure reported by AstraZeneca as a harbinger of sorrow for similar candidates in its own pipeline.

read more